Further support for diabetes treatments for Parkinson’s

A research group in South Korea has published results of their trial which provide further evidence that diabetes treatments can slow down the development of Parkinson’s in people with diabetes.


Important phase 1 trial results for LRRK2 inhibitor drug

This week the biotech company Denali Therapeutics announced the results of a phase 1 clinical trial of their LRRK2 inhibitor drug called ‘DNL151’. Their findings have interesting implications for the Parkinson’s community.


Fundraising news

The Virtual Royal Parks Half 2021

On Sunday 11 April, Cure Parkinson’s supporters François Berrier, Sharon Dawson, Vonnie Newton, Tammy Kustow, Jon Sellen and Natalie Gedra took part in the Virtual Royal Parks Half Marathon. Together, our fantastic fundraisers raised over £12,600 for our research! Originally, the Royal Parks Half was…


Documentary: ‘The Parkinson’s Drug Trial: A Miracle Cure?’

This award winning documentary was first broadcast in 2019 and features trial participants, including our late co-founder Tom Isaacs, in a cutting-edge drug trial involving complex brain surgery; and it is hoped it will be broadcast again in 2021.


The Duchess of Gloucester and Mike Tindall mark Parkinson’s Awareness Month

April marks World Parkinson’s Awareness Month to highlight the condition that affects some seven to 10 million people globally. At the centre of this month is World Parkinson’s Day on 11 April.